Funding · Healthcare & Life Sciences
Nivaan Care raises $7 million in Series A to scale its pain management clinics
By Startup Enthusiast ·
- Date
- Company
- Nivaan Care
- What it does
- specialized pain management clinics
- Kind
- Funding
- Amount
- $7M
- Stage
- Series A
- Founded
- 2023
What they do
Nivaan Care provides non-surgical, minimally invasive treatments for chronic pain, including back, neck, and knee pain
What happened
The $7 million Series A funding will be used to expand the clinic network and strengthen clinical and operational infrastructure
Why it matters
The startup aims to grow from 15 to 60–75 clinics over the next four years, addressing a significant gap in India's healthcare system
The details
- Nivaan Care, a single-specialty interventional pain management clinic, raised $7 million in a Series A funding round led by Sorin Investments.
- The funding includes participation from existing investors W Health Ventures, Endiya Partners, and Rebright Partners.
- The company previously raised $4.25 million in a seed round in February 2025, bringing its total capital raised to over $12 million.
- The new funds will be used to expand the clinic network into new major cities, enhance digital and clinical infrastructure, and scale non-surgical intervention programs.
- Nivaan Care currently operates clinics in Delhi-NCR, Mumbai, Jaipur, and Lucknow.
The bigger picture
- India has fewer than 200 interventional pain clinics, compared to over 4,000 in the US, highlighting a significant gap in chronic pain care.
- Nivaan’s model focuses on the 'middle layer' of care, offering minimally invasive treatments that avoid major surgery.
- The startup has served over 40,000 patients and performed more than 5,000 minimally invasive procedures.
- 90% of Nivaan’s patients have avoided major surgeries through its protocols, demonstrating clinical effectiveness.
About the business
- Nivaan Care operates single-specialty pain management clinics focused on chronic pain, including back, knee, and neck pain.
- The startup follows a multidisciplinary care model, combining pain physicians, physiotherapists, and care coordinators.
- Treatments include minimally invasive procedures such as Radiofrequency Ablation and Platelet-Rich Plasma (PRP) therapy.
- Nivaan aims to scale its model to 60–75 clinics over the next four years, targeting major Indian cities.
- The company’s approach addresses a critical gap in India’s healthcare system, where treatment options often oscillate between temporary relief and invasive surgery.
What happens next
- Nivaan Care plans to expand its clinic network to new major cities.
- The company aims to strengthen its clinical and operational infrastructure.
- It will continue innovating on new-age minimally invasive pain management procedures.
The deal
- Type
- funding
Investors
- Sorin Investments (lead) — Investor focused on scaling healthcare platforms.
- W Health Ventures (existing)
- Endiya Partners (existing)
- Rebright Partners (existing)
Founders
- Nivesh Khandelwal, Co-founder & CEO
- Vishwas Singh, Co-founder & COO
About Nivaan Care
- Product
- Single-specialty chronic pain management clinics and care programs
- Customers
- Patients seeking treatment for chronic back, knee, neck and related pain
- How it makes money
- Earns revenue from clinic-based consultations, procedures and care plans
- What sets it apart
- Uses a multidisciplinary, minimally invasive approach to pain management
- Operations
- Runs clinics across Delhi-NCR and other Indian cities
Other articles talking about it
Same day
- Shadowfax shares slip on stock market debut27 January 2026 · IPO · ₹1,907 crore
- Drishti IAS reports revenue of Rs 364 crore and PAT of Rs 61 crore in FY2527 January 2026 · Results
- Taghash launches execution service for VC and PE firms27 January 2026 · Launch
- Navam Capital raises over 315 crore for its first fund27 January 2026 · New fund · >₹315 crore (~$35M)
- 4baseCare raises ₹90 crore in Series B27 January 2026 · Funding · ₹90 crore
- Swiggy launches AI integration across food and grocery services27 January 2026 · Launch